Oral thin films have moved from a niche format to a regular option in product development, for prescription medicines, nutraceuticals and other dose formats. Published forecasts differ in scope and base year, so it is worth reading both the figure and its source before using it in a business case.
Market Size: What the Published Forecasts Say
- Coherent Market Insights estimates the global oral thin films market at USD 3.73 billion in 2026, reaching USD 7.18 billion by 2033, a CAGR of 9.8% over 2026–2033[1].
- The Business Research, cited in Aligned Machinery company material, projects USD 8.59 billion by 2029 at a CAGR of 14.5%.
- MarketsandMarkets puts the wider pharmaceutical packaging equipment market at USD 10.6 billion in 2025, reaching USD 14.3 billion by 2030, a CAGR of 6.3%[3].
The spread between these figures comes from different definitions of the category and different base years. For capacity planning, the growth direction is more useful than a single number.
1. Patient-Centric Dosing
Conventional tablets and capsules do not suit every patient. Paediatric and elderly patients, and people with dysphagia, often have difficulty swallowing solid dose forms. Aligned Machinery lists the practical attributes of oral strips as follows: high dosing accuracy; quick dissolving and fast release; no swallowing difficulty, with high acceptance by elderly and children; and a small, portable format.
Sublingual films account for the largest share of the oral thin film market at 56.6%, reflecting their ease of administration and their suitability for acute use, where a faster onset of action matters[1]. Neurological conditions also feature in demand: schizophrenia accounts for the largest share by disease indication, at 56.6%, partly because long-term adherence is easier to support with a format that does not require water[1].
Population ageing adds to this. Parkinson’s Foundation data for 2021 report more than 10 million people living with Parkinson’s disease worldwide, and project that the number of people with the condition in the United States will rise to 1.2 million by 2030[2].
2. ODF Beyond Prescription Pharmaceuticals
ODF production is no longer limited to prescription medicines. Aligned Machinery’s ODF lines support pharmaceutical, nutraceutical and pet care applications, and the company has published material on ODF production across industries[6]. Vitamins, melatonin and other supplement products delivered as films now compete with capsules and gummies, which brings buyers into the market who do not have existing film expertise and therefore look for suppliers that can support formulation as well as equipment.
3. Equipment Improvements
Early film production relied on manual steps that were difficult to reproduce. Current equipment automates the sequence and adds control and inspection at each stage: On Aligned Machinery ODF equipment, parts in contact with the product are made of 316L stainless steel, while other parts are generally 304L stainless steel and can be supplied in 316L where the project requires it.
- Continuous casting and drying: the ZM-340-4M runs unwinding, coating, drying and rewinding in one continuous sequence at 0.1–1.5 m/min, with a maximum casting width of 360 mm and temperature control of 30–80 °C ±2 °C.
- Independently controlled drying: the drying oven is divided into partitions with separate automatic control of temperature, humidity and concentration, and the drying section can be lengthened to suit the required output.
- Thickness consistency: Aligned Machinery specifies thickness consistency within ±2 µm for its ODF lines.
- Conditioning and printing: the KFG-380 peels film from the carrier, conditions and slits it at 0.002–5 m/min, and can apply laser printing.
- In-line inspection and reject: the KFM-300H includes visual inspection for edge rolling, missing parts and damage as standard, plus a pneumatic reject device on a vacuum adsorption conveyor, and packs at up to 1,200 packs per minute.
- Compliance by design: material-contact parts are made of stainless steel and non-toxic materials meeting GMP requirements; the lower transmission area and upper operation area are sealed and isolated by stainless steel plates; and electrical components, wiring and operating schemes comply with UL safety standards.
4. Contract Manufacturing Capacity
Contract development and manufacturing organizations are a significant route to market for film products, particularly for companies without their own film capability.
- Global Market Insights values the pharmaceutical CDMO market at USD 173.7 billion in 2025, projecting USD 342 billion by 2035, a CAGR of 7.1% over 2026–2035[4].
- Grand View Research estimates the oral solid dosage contract manufacturing market at USD 11.1 billion in 2026, reaching USD 21.3 billion by 2033, a CAGR of 9.7% over 2026–2033[5].
For CDMOs, film production is a distinct capability: casting, drying and precision slitting need different process controls from tablet presses or capsule fillers, and clients increasingly ask for formulation development and scale-up alongside equipment.
5. Turnkey Delivery Reduces Project Risk
Film lines involve more interfaces than a single machine: casting output has to match drying capacity, drying has to match slitting and packaging speed, and film handling has to be consistent across all of them. Sourcing each step separately puts the coordination burden on the buyer.
Aligned Machinery structures projects in five stages – engineering (plant layout, cleanroom design, URS review), procurement, construction (FAT and SAT verification, on-site installation and assembly), validation (IQ/OQ/PQ documentation and operator training) and support – so accountability for the line sits with one engineering team. The company entered the oral dissolving film equipment market in 2018, holds more than 68 independently developed patents, and serves more than 550 companies in over 100 countries, with ODF lines delivered to customers in the USA, Canada, India and other markets. CE documentation is available for the products supplied.
Regional Picture
Coherent Market Insights reports North America as the largest regional market at 39.9% share, with Asia Pacific the fastest growing region, as pharmaceutical companies expand film manufacturing capacity in India, China and South Korea[1]. For equipment buyers this matters in two ways: capacity is being added in Asia Pacific, and equipment suppliers in the region are closer to that expansion.
FAQ
How large is the oral thin film market?
Coherent Market Insights estimates USD 3.73 billion in 2026, reaching USD 7.18 billion by 2033, a CAGR of 9.8%. Aligned Machinery company material cites a separate projection of USD 8.59 billion by 2029 at a CAGR of 14.5% from The Business Research. The figures differ because the category definition and base year differ, so check both when building a business case.
Why are manufacturers adopting oral thin films?
The practical reasons are dosing convenience for patients who have difficulty swallowing tablets or capsules, quick dissolving and fast release, accurate dosing in a small portable format, and the extension of the format into nutraceutical and pet care products. Sublingual films hold the largest product share at 56.6%, and schizophrenia the largest share by disease indication at 56.6%.
Which industries use ODF production equipment?
Aligned Machinery ODF lines are used in pharmaceutical, nutraceutical and pet care applications, at different production scales. Within the wider equipment range, application industries also include veterinary, herbal and traditional medicine, and research and development laboratories.
What equipment advances have improved ODF production?
Continuous casting and drying on one machine, drying ovens divided into independently controlled partitions for temperature, humidity and concentration, thickness consistency within +/-2 micrometres, integrated slitting with laser printing, and in-line visual inspection with automatic reject at the packaging stage. On the KFM-300H, one slitting machine can support three packaging machines, which helps balance line output.
How does Aligned Machinery support companies entering ODF production?
Support starts with formula testing on pilot-scale equipment, continues through process design, equipment manufacturing and integration, FAT and SAT verification, on-site installation and commissioning, and covers IQ/OQ/PQ documentation support and operator training. Since 2019 the company has run 1,369 formula tests and 2,312 equipment commissioning runs with more than 200 enterprises. CE documentation is available for the products supplied.
Conclusion
ODF adoption is being driven by dosing convenience, a wider range of applications, more capable and better-controlled equipment, contract manufacturing capacity, and delivery models that consolidate project responsibility. For manufacturers evaluating capacity, the practical questions are which formulation and output the line has to serve, and whether the supplier can support formulation work as well as equipment supply.
To discuss ODF equipment or arrange formula testing, contact Aligned Machinery.
References
[1] Coherent Market Insights. “Oral Thin Films Market Size and Share Analysis – Growth Trends and Forecasts (2026–2033).” https://www.coherentmarketinsights.com/market-insight/oral-thin-films-market-5236
[2] Parkinson’s Foundation. “Parkinson’s Disease Statistics.” 2021. Cited in Coherent Market Insights, Oral Thin Films Market report.
[3] MarketsandMarkets. “Pharmaceutical Packaging Equipment Market Report 2025–2030.” https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.html
[4] Global Market Insights. “Pharmaceutical CDMO Market Size, Report 2026–2035.” https://www.gminsights.com/industry-analysis/pharmaceutical-cdmo-market
[5] Grand View Research. “Oral Solid Dosage Contract Manufacturing Market (2026–2033).” https://www.grandviewresearch.com/industry-analysis/oral-solid-dosage-osd-contract-manufacturing-market-report
[6] Aligned Machinery, “ODF Production Across Industries.” https://www.odfsolution.com/news/odf-production-across-industries/
[7] Aligned Machinery, “ZM-340-4M Automatic Oral Thin Film Making Machine.” https://www.odfsolution.com/zm-340-4m-automatic-oral-thin-film-making-machine-product/
[8] Aligned Machinery, “KFM-300H High Speed Oral Disintegrating Film Packaging Machine.” https://www.odfsolution.com/kfm-300h-high-speed-oral-disintegrating-film-packaging-machine-product/
[9] Aligned Machinery, “ODF Solution.” https://www.odfsolution.com/solution/
[10] The Business Research, “Oral Thin Film Market outlook to 2029, CAGR 14.5%, market size USD 8.59 billion,” cited in Aligned Machinery ODF production line material.
Post time: Aug-09-2026